US PATENT SUBCLASS 424 / 132.1
.~ Derived from transgenic multicellular eukaryote (e.g., plant, etc.)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

130.1  DF  IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL {18}
132.1.~ Derived from transgenic multicellular eukaryote (e.g., plant, etc.)

DEFINITION

Classification: 424/132.1

Derived from transgenic multicellular eukaryote (e.g., plant, etc.):

(under subclass 130.1) Subject matter wherein the material is produced in a transgenic multicellular eukaryote.

(1) Note. A transgenic multicellular eukaryote is a multicellular eukaryote whose genome carries a stable, heritable genetic sequence derived from an exogenous source (e.g., another species).

(2) Note. A multicellular eukaryote is a multicellular organism whose cells each contain a nucleus, defined by a nuclear membrane, wherein the nucleus contains chromosomes that constitute the organism's genome. Multicellular eukaryotes include multicellular plants and animals.

(3) Note. It is suggested that the patents in this subclass be cross-referenced to the appropriate subclass(es) that provide for the binding specificities of the antibodies, if disclosed.